Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Allen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Drug Targeting|July 30, 2005
Inhibition of choline uptake by N-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood-brain barrierWerner J Geldenhuys, Paul R Lockman, Ashok E Philip, et al.
Neuroreport|April 4, 2002
A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down syndromeDavid D Allen, Ana María Cárdenas, Christian Arriagada, et al.
American Journal of Pharmaceutical Education|June 8, 2025
Response to Engle and Colleagues "Commentary on AACP Argus Commission Forecast 2024"David D Allen, Todd D Sorensen, Anne Y F Lin, et al.
Bioorganic & Medicinal Chemistry|May 10, 2005
3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, Tiffany H Nguyen, et al.
Experimental Neurology|November 14, 2002
Cell lines derived from hippocampal neurons of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function, and functional neurotransmitter receptorsAna María Cárdenas, Christian Arriagada, David D Allen, et al.
American Journal of Pharmaceutical Education|March 12, 2010
Report of the 2008-2009 Professional Affairs Committee: The academy's leadership agenda for meeting academic and practice workforce demands through postgraduate professional educationCaroline A Gaither, David D Allen, Douglas C Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2010
Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporterWerner J Geldenhuys, Vamshi K Manda, Rajendar K Mittapalli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2007
Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrierPaul R Lockman, Vamshi K Manda, Werner J Geldenhuys, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine releasePeter A Crooks, Joshua T Ayers, Rui Xu, et al.
Journal of Neuroscience Research|April 5, 2002
Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down syndromeAna María Cárdenas, David D Allen, Christian Arriagada, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Drug Targeting|July 30, 2005
Inhibition of choline uptake by N-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood-brain barrierWerner J Geldenhuys, Paul R Lockman, Ashok E Philip, et al.
Neuroreport|April 4, 2002
A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down syndromeDavid D Allen, Ana María Cárdenas, Christian Arriagada, et al.
American Journal of Pharmaceutical Education|June 8, 2025
Response to Engle and Colleagues "Commentary on AACP Argus Commission Forecast 2024"David D Allen, Todd D Sorensen, Anne Y F Lin, et al.
Bioorganic & Medicinal Chemistry|May 10, 2005
3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, Tiffany H Nguyen, et al.
Experimental Neurology|November 14, 2002
Cell lines derived from hippocampal neurons of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function, and functional neurotransmitter receptorsAna María Cárdenas, Christian Arriagada, David D Allen, et al.
American Journal of Pharmaceutical Education|March 12, 2010
Report of the 2008-2009 Professional Affairs Committee: The academy's leadership agenda for meeting academic and practice workforce demands through postgraduate professional educationCaroline A Gaither, David D Allen, Douglas C Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2010
Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporterWerner J Geldenhuys, Vamshi K Manda, Rajendar K Mittapalli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2007
Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrierPaul R Lockman, Vamshi K Manda, Werner J Geldenhuys, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine releasePeter A Crooks, Joshua T Ayers, Rui Xu, et al.
Journal of Neuroscience Research|April 5, 2002
Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down syndromeAna María Cárdenas, David D Allen, Christian Arriagada, et al.
Pageof 6